Eggmanone Effectively Overcomes Prostate Cancer Cell Chemoresistance
Prostate cancer chemoresistance is a major therapeutic problem, and the underlying mechanism is not well understood and effective therapies to overcome this problem are not available. Phosphodiesterase-4 (PDE4), a main intracellular enzyme for cAMP hydrolysis, has been previously shown to involve in...
Main Authors: | Chen Xie, Pen-Jen Lin, Jijun Hao |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-05-01
|
Series: | Biomedicines |
Subjects: | |
Online Access: | https://www.mdpi.com/2227-9059/9/5/538 |
Similar Items
-
Bromocriptine monotherapy overcomes prostate cancer chemoresistance in preclinical models
by: Lijuan Bai, et al.
Published: (2023-08-01) -
Necroptosis Induced by Delta-Tocotrienol Overcomes Docetaxel Chemoresistance in Prostate Cancer Cells
by: Marina Montagnani Marelli, et al.
Published: (2023-03-01) -
Targeting Glioblastoma Stem Cells to Overcome Chemoresistance: An Overview of Current Therapeutic Strategies
by: Hyunkoo Kang, et al.
Published: (2022-06-01) -
MDA-9/Syntenin (SDCBP) Is a Critical Regulator of Chemoresistance, Survival and Stemness in Prostate Cancer Stem Cells
by: Sarmistha Talukdar, et al.
Published: (2019-12-01) -
rRNA-Derived Small RNA rsRNA-28S Regulates the Chemoresistance of Prostate Cancer Cells by Targeting PTGIS
by: Deqian Qiao, et al.
Published: (2023-05-01)